Projects per year
Personal profile
Personal profile
Dr. Andrew Farach is an associate professor in the Department of Radiation Oncology at Houston Methodist Hospital. His interest and special procedures are in breast cancer, brain cancer, gynecologic cancer, lung cancer, hepatobiliary cancer, gastrointestinal cancer, lymphoma, brachytherapy, stereotactic radiation/surgery.
Dr. Farach earned his medical degree from Thomas Jefferson University, Jefferson Medical College in Philadelphia. He completed his internship at the University of Texas Health Science Center and his radiation oncology residency training at Baylor College of Medicine. He became Director of Brachytherapy in the Department of Radiation Oncology at Houston Methodist in 2018. Dr. Farach is active in ASTRO (American Society of Therapeutic Radiology and Oncology), ACR (American College of Radiology), and the Texas Radiological Society (TRS). Dr. Farach has published peer-reviewed articles on topics such as SBRT outcomes in lung cancer, radiation and immunotherapy for breast cancer, and liver regeneration after SBRT. He plays an important role in cancer patient care, clinical research and the education of residents and students.
External positions
Associate Professor of Clinical Radiation Oncology, Weill Cornell Medical College
Nov 1 2022 → …
Research Area Keywords
- Imaging & Radiology
- Cancer
- Clinical Translation & Trials
- Clinical Care
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
A Phase II Clinical tRial of neoADjuVant sAsanlimab and stereotaCtiC body radIatioN thErapy as an in situ vaccine for cisplatin-ineligible Muscle Invasive Bladder Cancer (RAD VACCINE MIBC)
Satkunasivam, R., Butler, E. B., Chen, S., Esnaola, N. F., Farach, A. M., Teh, B. S. & Zhang, J.
1/20/22 → …
Project: Clinical Trial
-
A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination withIntravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVACancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer.
Zaid, T., Butler, E. B., Darcourt, J., Farach, A. M., Kamat, A. A., Shkedy, C., Singh, M. & Suri, A.
3/1/14 → 2/28/39
Project: Non Profit
-
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative
Niravath, P. A., Butler, E. B., Chang, J. C., Farach, A. M., Haque, W. M., Heyne, K., Morgan, P. B. & Teh, B. S.
Project: Clinical Trial
-
Comparative real-world survival outcomes of muscle-invasive bladder cancer treated with bladder-only vs. whole-pelvis concurrent chemoradiation
Riveros, C., Ranganathan, S., Haque, W., Huang, E., Xu, J., Kulkarni, G. S., Geng, M., Anis, M., Muhammad, T., Chan, K. S., Farach, A., Teh, B. S., Miles, B. J., Klaassen, Z., Sonpavde, G. P., Wallis, C. J. D. & Satkunasivam, R., Feb 2024, In: Journal of the Canadian Urological Association. 18, 2, p. 17-24 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A feasibility study of utilizing a cadaveric training model for novel robotic bladder cancer brachytherapy techniques
Patel, A., Orakwue, C. W., Olek, D., Guzman, J. C. A., Lim, K., Pino, R., Teh, B. S., Butler, B., Satkunasivam, R. & Farach, A., Mar 1 2023, In: Brachytherapy. 22, 2, p. 195-198 4 p.Research output: Contribution to journal › Article › peer-review
-
A Phase 2 Study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung Cancer
Guan, J., Sun, K., Guerrero, C. A., Zheng, J., Xu, Y., Mathur, S., Teh, B. S., Farach, A., Zhang, J., Butler, E., Pan, P. Y., Zsigmond, E., Mei, Z., Mejia, J., Chen, S. H., Chang, J. C. & Bernicker, E. H., Aug 24 2023, (E-pub ahead of print) In: International Journal of Radiation Oncology Biology Physics. 118, 5, p. 1531-1540 10 p.Research output: Contribution to journal › Article › peer-review
-
Focal versus whole gland salvage brachytherapy for recurrent prostate cancer in the prostate specific membrane antigen PET era: a narrative review
Andring, L. M., Teh, B. S., Butler, E. B. & Farach, A. M., Jun 2023, In: Chinese Clinical Oncology. 12, 3, p. 26 26.Research output: Contribution to journal › Review article › peer-review
Open Access -
Leptomeningeal metastasis from neuroendocrine carcinoma of the cervix: illustrative case
Patterson, J. D., Farach, A. M., Singh, M., Britz, G. W. & Rostomily, R. C., Jan 30 2023, In: Journal of Neurosurgery: Case Lessons. 5, 5, CASE22457.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations